Stefan Seregard

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: BMC CANCER. 2023;23(1):277
A serum protein signature at the time of Uveal Melanoma diagnosis predicts long-term patient survival
Herrspiegel C; Plastino F; Lardner E; Seregard S; Williams PA; Andre H; Stalhammar G
Article: BMC OPHTHALMOLOGY. 2023;23(1):88
Increasing demand for ophthalmic pathology: time trends in a laboratory with nationwide coverage
Stalhammar G; Lardner E; Georgsson M; Seregard S
Article: ACTA OPHTHALMOLOGICA. 2023;101(1):34-48
A prognostic classification system for uveal melanoma based on a combination of patient age and sex, the American Joint Committee on Cancer and the Cancer Genome Atlas models
Gill VT; Sabazade S; Herrspiegel C; Ewens KG; Opalko A; Dan N; Christersdottir T; Berg Rendahl A; Shields CL; Seregard S; Ganguly A; Stalhammar G
Article: BRITISH JOURNAL OF OPHTHALMOLOGY. 2023;107(1):127-132
Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging.
Tomar AS; Finger PT; Gallie B; Kivelä T; Mallipatna A; Zhang C; Zhao J; Wilson M; Brennan R; Burges M; Kim J; Berry JL; Jubran R; Khetan V; Ganeshan S; Yarovoy A; Yarovaya V; Kotova E; Volodin D; Yousef Y; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada GL; Schaiquevich P; Fandiño AC; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català-Mora J; Correa Llano M; Carreras E; American Joint Committee on Cancer Ophthalmic Onco; American Joint Committee on Cancer Ophthalmic Onco
Article: BRITISH JOURNAL OF OPHTHALMOLOGY. 2022;106(4):510-517
Patients presenting with metastases: stage IV uveal melanoma, an international study
Garg G; Finger PT; Kivela TT; Simpson ER; Gallie BL; Saakyan S; Amiryan AG; Valskiy V; Chin KJ; Semenova E; Seregard S; Fili M; Wilson M; Haik B; Caminal JM; Catala-Mora J; Gutierrez C; Pelayes DE; Folgar AM; Jager MJ; Dogrusoz M; Luyten GPM; Singh AD; Suzuki S
Article: ONCOGENE. 2022;41(4):600-611
IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma
Song D; Cismas S; Crudden C; Trocme E; Worrall C; Suleymanova N; Lin T; Zheng H; Seregard S; Girnita A; Girnita L
Article: FRONTIERS IN MEDICINE. 2022;9:926034
Trends in Uveal Melanoma Presentation and Survival During Five Decades: A Nationwide Survey of 3898 Swedish Patients
Gill V; Herrspiegel C; Sabazade S; Fili M; Bergman L; Damato B; Seregard S; Stalhammar G
Article: BRITISH JOURNAL OF OPHTHALMOLOGY. 2021;105(10):1435-1443
Travel burden and clinical presentation of retinoblastoma: analysis of 1024 patients from 43 African countries and 518 patients from 40 European countries.
Fabian ID; Stacey AW; Foster A; Kivelä TT; Munier FL; Keren-Froim N; Gomel N; Cassoux N; Sagoo MS; Reddy MA; Harby LA; Zondervan M; Bascaran C; Abdallah E; Abdullahi SU; Boubacar SA; Ademola-Popoola DS; Adio A; Aghaji AE; Portabella SA; Alfa Bio AI; Ali AM; Alia DB; All-Eriksson C; Almeida AA; Alsawidi KM; Antonino R; Astbury NJ; Atsiaya R; Balaguer J; Balwierz W; Barranco H; Popovic MB; Benmiloud S; Guebessi NB; Berete RC; Biddulph SJ; Biewald EM; Blum S; Bobrova N; Boehme M; Bornfeld N; Bouda GC; Bouguila H; Boumedane A; Brichard BG; L MC; Castela G; Català-Mora J; Chantada GL; Chernodrinska VS; Chiwanga FS; Cieslik K; Comsa C; Correa Llano MG; Csóka M; Da Gama IV; Davidson A; Potter PD; Desjardins L; Dragomir MD; Bruyn MD; Kettani AE; Elbahi AM; Elgalaly D; Elhaddad AM; Ali Elhassan MM; Elzembely MM; Essuman VA; Evina TGA; Fasina O; Fernández-Teijeiro A; Gandiwa M; Aldana DG; Geel JA; Gizachew Z; Gregersen PA; Guedenon KM; Hadjistilianou T; Hassan S; Hederova S; Hessissen L; Hordofa DF; Hummlen M; Husakova K; Ida R; Ilic VR; Jenkinson H; Amani Kabesha TB; Kabore RL; Kalinaki A; Kapelushnik N; Kardava T; Kemilev PK; Kepak T; Khotenashvili Z; Klett A; Kosh Komba Palet JE; Krivaitiene D; Kruger M; Kyara A; Lachmann ES; Latinović S; Lecuona K; Lukamba RM; Lumbroso L; Lysytsia L; Maka E; Makan M; Manda C; Begue NM; Matende IO; Matua M; Mayet I; Mbumba FB; Mengesha AA; Midena E; Mndeme FG; Mohamedani AA; Moll AC; Moreira C; Msina MS; Msukwa G; Muma KI; Murgoi G; Musa KO; Mustak H; Muyen OM; Naidu G; Naumenko L; Ndoye Roth PA; Neroev V; Nikitovic M; Nkanga ED; Nkumbe H; Nyaywa M; Obono-Obiang G; Oguego NC; Olechowski A; Oscar AH; Osei-Bonsu P; Painter SL; Paintsil V; Paiva L; Papyan R; Parrozzani R; Parulekar M; Pawinska-Wasikowska K; Perić S; Philbert R; Pochop P; Polyakov VG; Pompe MT; Pons JJ; Raobela L; Renner LA; Reynders D; Ribadu D; Riheia MM; Ritter-Sovinz P; Saakyan S; Said AM; Román Pacheco SS; Scanlan TA; Schoeman J; Seregard S; Sherief ST; Cheikh SS; Silva S; Sorochynska T; Ssali G; Stathopoulos C; Kranjc BS; Stones DK; Svojgr K; Sylla F; Tamamyan G; Tandili A; Tateshi B; Theophile T; Traoré F; Tyau-Tyau H; Umar AB; Urbak SF; Ushakova TL; Valeina S; Hoefen Wijsard MV; Veleva-Krasteva NV; Viksnins M; Wackernagel W; Waddell K; Wade PD; Wali Nigeria AH; Wime AD; Dod CW; Yanga JM; Yarovaya VA; Yarovoy AA; Zein E; Sharabi S; Zhilyaeva K; Ziko OA; Bowman R
Article: BRITISH JOURNAL OF OPHTHALMOLOGY. 2021;105(10):1358-1364
Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study
Jain P; Finger PT; Fili M; Damato B; Coupland SE; Heimann H; Kenawy N; Brouwer N; Marinkovic M; Van Duinen SG; Caujolle JP; Maschi C; Seregard S; Pelayes D; Folgar M; Yousef YA; Krema H; Gallie B; Calle-Vasquez A
Article: BRITISH JOURNAL OF OPHTHALMOLOGY. 2021;105(4):582-586
Nuclear expression of BAP-1 in transvitreal incisional biopsies and subsequent enucleation of eyes with posterior choroidal melanoma
Herrspiegel C; Kvanta A; Lardner E; Cabaca LR; Wells J; Bartuma K; Seregard S; Stalhammar G
Article: BRITISH JOURNAL OF OPHTHALMOLOGY. 2021;105(1):57-62
Effect of plaque brachytherapy dose and dose rate on risk for disease-related mortality in 1238 patients with choroidal melanoma
Fili M; Trocme E; Herrspiegel C; Seregard S; Stalhammar G
Article: JAMA ONCOLOGY. 2020;6(5):685-695
Global Retinoblastoma Presentation and Analysis by National Income Level.
Global Retinoblastoma Study Group; Fabian ID; Abdallah E; Abdullahi SU; Abdulqader RA; Adamou Boubacar S; Ademola-Popoola DS; Adio A; Afshar AR; Aggarwal P; Aghaji AE; Ahmad A; Akib MNR; Al Harby L; Al Ani MH; Alakbarova A; Portabella SA; Al-Badri SAF; Alcasabas APA; Al-Dahmash SA; Alejos A; Alemany-Rubio E; Alfa Bio AI; Alfonso Carreras Y; Al-Haddad C; Al-Hussaini HHY; Ali AM; Alia DB; Al-Jadiry MF; Al-Jumaily U; Alkatan HM; All-Eriksson C; Al-Mafrachi AARM; Almeida AA; Alsawidi KM; Al-Shaheen AASM; Al-Shammary EH; Amiruddin PO; Antonino R; Astbury NJ; Atalay HT; Atchaneeyasakul L-O; Atsiaya R; Attaseth T; Aung TH; Ayala S; Baizakova B; Balaguer J; Balayeva R; Balwierz W; Barranco H; Bascaran C; Beck Popovic M; Benavides R; Benmiloud S; Bennani Guebessi N; Berete RC; Berry JL; Bhaduri A; Bhat S; Biddulph SJ; Biewald EM; Bobrova N; Boehme M; Boldt HC; Bonanomi MTBC; Bornfeld N; Bouda GC; Bouguila H; Boumedane A; Brennan RC; Brichard BG; Buaboonnam J; Calderón-Sotelo P; Calle Jara DA; Camuglia JE; Cano MR; Capra M; Cassoux N; Castela G; Castillo L; Català-Mora J; Chantada GL; Chaudhry S; Chaugule SS; Chauhan A; Chawla B; Chernodrinska VS; Chiwanga FS; Chuluunbat T; Cieslik K; Cockcroft RL; Comsa C; Correa ZM; Correa Llano MG; Corson TW; Cowan-Lyn KE; Csóka M; Cui X; Da Gama IV; Dangboon W; Das A; Das S; Davanzo JM; Davidson A; De Potter P; Delgado KQ; Demirci H; Desjardins L; Diaz Coronado RY; Dimaras H; Dodgshun AJ; Donaldson C; Donato Macedo CR; Dragomir MD; Du Y; Du Bruyn M; Edison KS; Eka Sutyawan IW; El Kettani A; Elbahi AM; Elder JE; Elgalaly D; Elhaddad AM; Elhassan MMA; Elzembely MM; Essuman VA; Evina TGA; Fadoo Z; Fandiño AC; Faranoush M; Fasina O; Fernández DDPG; Fernández-Teijeiro A; Foster A; Frenkel S; Fu LD; Fuentes-Alabi SL; Gallie BL; Gandiwa M; Garcia JL; García Aldana D; Gassant PY; Geel JA; Ghassemi F; Girón AV; Gizachew Z; Goenz MA; Gold AS; Goldberg-Lavid M; Gole GA; Gomel N; Gonzalez E; Gonzalez Perez G; González-Rodríguez L; Garcia Pacheco HN; Graells J; Green L; Gregersen PA; Grigorovski NDAK; Guedenon KM; Gunasekera DS; Gündüz AK; Gupta H; Gupta S; Hadjistilianou T; Hamel P; Hamid SA; Hamzah N; Hansen ED; Harbour JW; Hartnett ME; Hasanreisoglu M; Hassan S; Hassan S; Hederova S; Hernandez J; Hernandez LMC; Hessissen L; Hordofa DF; Huang LC; Hubbard GB; Hummlen M; Husakova K; Hussein Al-Janabi AN; Ida R; Ilic VR; Jairaj V; Jeeva I; Jenkinson H; Ji X; Jo DH; Johnson KP; Johnson WJ; Jones MM; Kabesha TBA; Kabore RL; Kaliki S; Kalinaki A; Kantar M; Kao L-Y; Kardava T; Kebudi R; Kepak T; Keren-Froim N; Khan ZJ; Khaqan HA; Khauv P; Kheir WJ; Khetan V; Khodabande A; Khotenashvili Z; Kim JW; Kim JH; Kiratli H; Kivelä TT; Klett A; Komba Palet JEK; Krivaitiene D; Kruger M; Kulvichit K; Kuntorini MW; Kyara A; Lachmann ES; Lam CPS; Lam GC; Larson SA; Latinovic S; Laurenti KD; Le BHA; Lecuona K; Leverant AA; Li C; Limbu B; Long QB; López JP; Lukamba RM; Lumbroso L; Luna-Fineman S; Lutfi D; Lysytsia L; Magrath GN; Mahajan A; Majeed AR; Maka E; Makan M; Makimbetov EK; Manda C; Martín Begue N; Mason L; Mason JO; Matende IO; Materin M; Mattosinho CCDS; Matua M; Mayet I; Mbumba FB; McKenzie JD; Medina-Sanson A; Mehrvar A; Mengesha AA; Menon V; Mercado GJVD; Mets MB; Midena E; Mishra DKC; Mndeme FG; Mohamedani AA; Mohammad MT; Moll AC; Montero MM; Morales RA; Moreira C; Mruthyunjaya P; Msina MS; Msukwa G; Mudaliar SS; Muma KI; Munier FL; Murgoi G; Murray TG; Musa KO; Mushtaq A; Mustak H; Muyen OM; Naidu G; Nair AG; Naumenko L; Ndoye Roth PA; Nency YM; Neroev V; Ngo H; Nieves RM; Nikitovic M; Nkanga ED; Nkumbe H; Nuruddin M; Nyaywa M; Obono-Obiang G; Oguego NC; Olechowski A; Oliver SCN; Osei-Bonsu P; Ossandon D; Paez-Escamilla MA; Pagarra H; Painter SL; Paintsil V; Paiva L; Pal BP; Palanivelu MS; Papyan R; Parrozzani R; Parulekar M; Pascual Morales CR; Paton KE; Pawinska-Wasikowska K; Pe'er J; Peña A; Peric S; Pham CTM; Philbert R; Plager DA; Pochop P; Polania RA; Polyakov VG; Pompe MT; Pons JJ; Prat D; Prom V; Purwanto I; Qadir AO; Qayyum S; Qian J; Rahman A; Rahman S; Rahmat J; Rajkarnikar P; Ramanjulu R; Ramasubramanian A; Ramirez-Ortiz MA; Raobela L; Rashid R; Reddy MA; Reich E; Renner LA; Reynders D; Ribadu D; Riheia MM; Ritter-Sovinz P; Rojanaporn D; Romero L; Roy SR; Saab RH; Saakyan S; Sabhan AH; Sagoo MS; Said AMA; Saiju R; Salas B; San Román Pacheco S; Sánchez GL; Sayalith P; Scanlan TA; Schefler AC; Schoeman J; Sedaghat A; Seregard S; Seth R; Shah AS; Shakoor SA; Sharma MK; Sherief ST; Shetye NG; Shields CL; Siddiqui SN; Sidi Cheikh S; Silva S; Singh AD; Singh N; Singh U; Singha P; Sitorus RS; Skalet AH; Soebagjo HD; Sorochynska T; Ssali G; Stacey AW; Staffieri SE; Stahl ED; Stathopoulos C; Stirn Kranjc B; Stones DK; Strahlendorf C; Suarez MEC; Sultana S; Sun X; Sundy M; Superstein R; Supriyadi E; Surukrattanaskul S; Suzuki S; Svojgr K; Sylla F; Tamamyan G; Tan D; Tandili A; Tarrillo Leiva FF; Tashvighi M; Tateshi B; Tehuteru ES; Teixeira LF; Teh KH; Theophile T; Toledano H; Trang DL; Traoré F; Trichaiyaporn S; Tuncer S; Tyau-Tyau H; Umar AB; Unal E; Uner OE; Urbak SF; Ushakova TL; Usmanov RH; Valeina S; van Hoefen Wijsard M; Varadisai A; Vasquez L; Vaughan LO; Veleva-Krasteva NV; Verma N; Victor AA; Viksnins M; Villacís Chafla EG; Vishnevskia-Dai V; Vora T; Wachtel AE; Wackernagel W; Waddell K; Wade PD; Wali AH; Wang Y-Z; Weiss A; Wilson MW; Wime ADC; Wiwatwongwana A; Wiwatwongwana D; Wolley Dod C; Wongwai P; Xiang D; Xiao Y; Yam JC; Yang H; Yanga JM; Yaqub MA; Yarovaya VA; Yarovoy AA; Ye H; Yousef YA; Yuliawati P; Zapata López AM; Zein E; Zhang C; Zhang Y; Zhao J; Zheng X; Zhilyaeva K; Zia N; Ziko OAO; Zondervan M; Bowman R
Article: BRITISH JOURNAL OF OPHTHALMOLOGY. 2020;104(1):26-32
Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm
Fili M; Trocme E; Bergman L; See TRO; Andre H; Bartuma K; Girnita L; All-Eriksson C; Seregard S; Stalhammar G
Article: CANCERS. 2019;11(10):E1579-1579
Prediction of BAP1 Expression in Uveal Melanoma Using Densely-Connected Deep Classification Networks
Sun M; Zhou W; Qi X; Zhang G; Girnita L; Seregard S; Grossniklaus HE; Yao Z; Zhou X; Stalhammar G
Article: OCULAR ONCOLOGY AND PATHOLOGY. 2019;5(6):432-439
No Gender Differences in Long-Term Survival after Brachytherapy of 1,541 Patients with Uveal Melanoma
Stalhammar G; See TR; Fili M; Seregard S
Article: JAMA OPHTHALMOLOGY. 2019;137(8):905-911
Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma
Jain P; Finger PT; Damato B; Coupland SE; Heimann H; Kenawy N; Brouwer NJ; Marinkovic M; Van Duinen SG; Caujolle JP; Maschi C; Seregard S; Pelayes D; Folgar M; Yousef YA; Krema H; Gallie B; Calle-Vasquez A; Finger PT; Coupland SE; Albert DM; Amiryan AG; Saakyan S; Auw-Haedrich C; Baker D; Barnhill R; Caminal JM; Caroll WL; Cassoux N; Desjardins LG; Doz F; Pierron G; Catala-Mora J; Chantada G; Chevez-Barrios P; Conway RM; Damato BE; Demirci H; Dutton JJ; Esmaeli B; Prieto VG; Williams M; Gallie BL; Graue GF; Grossniklaus HE; Heegaard S; Holbach LM; Honavar SG; Jager MJ; Kivela T; Kujala E; Lumbroso-Le Rouic L; Mallipatna AC; Modorati GM; Munier FL; Murray TG; Pavlick AC; Pe'er J; Pelayes DE; Rodriguez MJ; Sauerwein WAG; Semenova E; Seregard S; Shields C; Simpson ER; Singh AD; Suzuki S; Washington MK; White VA; Wilson MW; Wittekind CW; Yin V
Article: AMERICAN JOURNAL OF OPHTHALMOLOGY. 2019;202:100-108
The Small Fatal Choroidal Melanoma Study. A Survey by the European Ophthalmic Oncology Group.
Jouhi S; Jager MJ; de Geus SJR; Desjardins L; Eide NA; Grange J-D; Kiilgaard JF; Seregard S; Midena E; Parrozzani R; Caujolle J-P; Rospond-Kubiak I; Kivelä TT
Article: CANCER MEDICINE. 2019;8(6):2784-2792
Expression of immune checkpoint receptors Indoleamine 2,3-dioxygenase and T cell Ig and ITIM domain in metastatic versus nonmetastatic choroidal melanoma
Stalhammar G; Seregard S; Grossniklaus HE
Article: TRANSLATIONAL VISION SCIENCE & TECHNOLOGY. 2019;8(3):11
Digital Image Analysis of BAP-1 Accurately Predicts Uveal Melanoma Metastasis
Stalhammar G; See TRO; Phillips S; Seregard S; Grossniklaus HE
Article: ACTA OPHTHALMOLOGICA. 2018;96(5):510-518
Tumour thickness, diameter, area or volume? The prognostic significance of conventional versus digital image analysis-based size estimation methods in uveal melanoma
Arnljots TS; Al-Sharbaty Z; Lardner E; All-Eriksson C; Seregard S; Stalhammar G
Article: LAKARTIDNINGEN. 2017;114:ELAR
[Melanoma in places other than the skin: eye and mucous membrane melanomas].
All-Eriksson C; Seregard S; Hansson J
Article: OPHTHALMOLOGY. 2016;123(4):898-907
The Pediatric Choroidal and Ciliary Body Melanoma Study A Survey by the European Ophthalmic Oncology Group
Al-Jamal RT; Cassoux N; Desjardins L; Damato B; Konstantinidis L; Coupland SE; Heimann H; Petrovic A; Zografos L; Schalenbourg A; Velazquez-Martin JP; Krema H; Bogdali A; Markiewicz A; Romanowska-Dixon B; Metz CHD; Biewald E; Bornfeld N; Kiratli H; Bronkhorst IHG; Jager MJ; Marinkovic M; Fili M; Seregard S; Frenkel S; Pe'er J; Salvi SM; Rennie IG; Rospond-Kubiak I; Kociecki J; Kiilgaard JF; Heegaard S; Cohen VML; Sagoo MS; Amiryan A; Saakyan S; Md NI; Krohn J; Midena E; Parrozzani R; Grange J-D; Kilic E; Blasi MA; Saornil MA; Kivela TT
Article: OPHTHALMOLOGY. 2016;123(1):86-91
Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma
Finger PT
Article: JAMA OPHTHALMOLOGY. 2015;133(4):376-383
International Validation of the American Joint Committee on Cancer's 7th Edition Classification of Uveal Melanoma
Finger PT
Article: BRITISH JOURNAL OF OPHTHALMOLOGY. 2014;98(10):1349-1354
High dose rate and low dose rate ruthenium brachytherapy for uveal melanoma. No association with ocular outcome
Fili M; Lundell G; Lundell M; Seregard S
Article: BRACHYTHERAPY. 2014;13(1):1-14
The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma.
American Brachytherapy Society - Ophthalmic Oncolo; ABS – OOTF Committee
Article: EYE. 2013;27(2):115-118
Diagnostic incisional biopsies in clinically indeterminate choroidal tumours
Seregard S; All-Ericsson C; Hjelmqvist L; Berglin L; Kvanta A
Article: OPHTHALMOLOGY. 2012;119(12):2587-2591
Benefit from Bevacizumab for Macular Edema in Central Retinal Vein Occlusion: Twelve-Month Results of a Prospective, Randomized Study
Epstein DL; Algvere PV; von Wendt G; Seregard S; Kvanta A
Article: ARCHIVES OF OPHTHALMOLOGY. 2012;130(9):1229
Angle involvement and glaucoma in patients with biopsy-proven iris melanoma: a response-reply.
Khan S; Finger PT; Yu G-P; Razzaq L; Jager MJ; de Keizer RJW; Sandkull P; Seregard S; Gologorsky D; Schefler AC; Murray TG; Kivelä T; Giuliari GP; McGowan H; Simpson ER; Corriveau C; Coupland SE; Damato BE
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2012;53(8):4442-4449
JARID1B Protein Expression and Prognostic Implications in Uveal Melanoma
Radberger P; Radberger A; Bykov VJN; Seregard S; Economou MA
Article: OPHTHALMOLOGY. 2012;119(6):1184-1189
Bevacizumab for Macular Edema in Central Retinal Vein Occlusion: A Prospective, Randomized, Double-Masked Clinical Study
Epstein DLJ; Algvere PV; von Wendt G; Seregard S; Kvanta A
Article: BRITISH JOURNAL OF OPHTHALMOLOGY. 2012;96(5):714-718
Combination therapy with low-dose transpupillary thermotherapy and intravitreal ranibizumab for neovascular age-related macular degeneration: a 24-month prospective randomised clinical study
Soderberg A-C; Algvere PV; Hengstler JC; Soderberg P; Seregard S; Kvanta A
Article: ACTA OPHTHALMOLOGICA. 2012;90(3):266-270
Intraoperative mitomycin C versus autologous conjunctival autograft in surgery of primary pterygium with four-year follow-up
Koranyi G; Artzen D; Seregard S; Kopp ED
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2012;109(18):7055-7060
Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor
Zheng H; Worrall C; Shen H; Issad T; Seregard S; Girnita A; Girnita L
Article: INTERNATIONAL JOURNAL OF CANCER. 2012;130(5):1120-1127
Nuclear HER3 is associated with favorable overall survival in uveal melanoma
Trocme E; Mougiakakos D; Johansson CC; All-Eriksson C; Economou MA; Larsson O; Seregard S; Kiessling R; Lin Y
Article: MONOGRAPHS IN CLINICAL CYTOLOGY. 2012;21:82-89
Fine needle aspiration cytology in orbital tumors.
Seregard S; Tani E
Article: ARCHIVES OF OPHTHALMOLOGY. 2012;130(1):57-64
Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study.
Khan S; Finger PT; Yu G-P; Razzaq L; Jager MJ; de Keizer RJW; Sandkull P; Seregard S; Gologorsky D; Schefler AC; Murray TG; Kivelä T; Giuliari GP; McGowan H; Simpson ER; Corriveau C; Coupland SE; Damato BE
Article: EUROPEAN JOURNAL OF OPHTHALMOLOGY. 2011;21(6):789-795
Intravitreal bevacizumab in central retinal vein occlusion: 18-month results of a prospective clinical trial
Algvere PV; Epstein D; von Wendt G; Seregard S; Kvanta A
Article: ACTA OPHTHALMOLOGICA. 2010;88(8):836-841
Visual improvement in central retinal vein occlusion (CRVO) following intravitreal injections of bevacizumab (Avastin®)
Algvere PV; von Wendt G; Gudmundsson J; Seregard S; Kvanta A
Article: ACTA OPHTHALMOLOGICA. 2010;88(4):394-400
Dystrophia Smolandiensis: a novel morphological picture of recurrent corneal erosions
Hammar B; Lagali N; Ek S; Seregard S; Dellby A; Fagerholm P
Article: INTERNATIONAL JOURNAL OF CANCER. 2010;126(11):2682-2689
Expression and prognostic significance of iNOS in uveal melanoma
Johansson CC; Mougiakakos D; Trocme E; All-Ericsson C; Economou MA; Larsson O; Seregard S; Kiessling R
Article: ACTA OPHTHALMOLOGICA. 2010;88(4):426-430
Vision-related function after low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degeneration
Odergren A; Algvere PV; Seregard S; Libert C; Kvanta A
Article: CANCER. 2010;116(9):2224-2233
Intratumoral Forkhead Box P3-Positive Regulatory T Cells Predict Poor Survival in Cyclooxygenase-2 Positive Uveal Melanoma
Mougiakakos D; Johansson CC; Trocme E; All-Ericsson C; Economou MA; Larsson O; Seregard S; Kiessling R
Article: BRITISH JOURNAL OF OPHTHALMOLOGY. 2009;93(11):1524-1528
Time trends in the incidence of conjunctival melanoma in Sweden
Triay E; Bergman L; Nilsson B; All-Ericsson C; Seregard S
Article: LAKARTIDNINGEN. 2009;106(35):2153-2154
[HSAN decision a threat against Swedish ophthalmologic care].
Seregard S
Article: ACTA OPHTHALMOLOGICA. 2009;87(4):464-467
Malignant solitary fibrous tumour of the orbit
Girnita L; Sahlin S; Orrego A; Seregard S
Article: ACTA OPHTHALMOLOGICA. 2008;86 Thesis 4:42-49
Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor.
Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
Article: ACTA OPHTHALMOLOGICA. 2008;86 Thesis 4:35-41
Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma.
Economou MA; Andersson S; Vasilcanu D; All-Ericsson C; Menu E; Girnita A; Girnita L; Axelson M; Seregard S; Larsson O
Article: ACTA OPHTHALMOLOGICA. 2008;86 Thesis 4:26-34
The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
Article: ACTA OPHTHALMOLOGICA. 2008;46:20-25
Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma. Intercorrelation and prognostic implications
Economou MA; Ericsson CA; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S
Article: ACTA OPHTHALMOLOGICA. 2008;86(5):482-489
A prospective study on intravitreal bevacizumab (Avastin®) for neovascular age-related macular degeneration of different durations
Algvere PV; Steen B; Seregard S; Kvanta A
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2008;49(6):2620-2626
Inhibition of VEGF secretion and experimental choroidal neovascularization by picropodophyllin (PPP), an inhibitor of the insulin-like growth factor-1 receptor
Economou MA; Wu J; Vasilcanu D; Rosengren L; All-Ericsson C; van der Ploeg I; Menu E; Girnita L; Axelson M; Larsson O; Seregard S; Kvanta A
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2008;49(6):2337-2342
Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma
Economou MA; Andersson S; Vasilcanu D; All-Ericsson C; Menu E; Girnita A; Girnita L; Axelson M; Seregard S; Larsson O
Article: BRITISH JOURNAL OF OPHTHALMOLOGY. 2008;92(6):757-761
A prospective randomised study on low-dose transpupillary thermotherapy versus photodynamic therapy for neovascular age-related macular degeneration
Odergren A; Algvere PV; Seregard S; Kvanta A
Article: OPHTHALMOLOGY. 2007;114(11):2055-2060
Preoperative sub-Tenon's capsule injection of ropivacaine in conjunction with general anesthesia in retinal detachment surgery
Bergman L; Backmark I; Ones H; von Euler C; Olivestedt G; Kvanta A; Steen B; Seregard S; Nilsson B; Berglin L
Article: JOURNAL OF CATARACT AND REFRACTIVE SURGERY. 2007;33(9):1619-1623
Safety of irrigation with 5-fluorouracil in a sealed-capsule irrigation device in the rabbit eye
Abdelwahab MT; Kugelberg M; Seregard S; Zetterstroem C
Article: ACTA OPHTHALMOLOGICA. 2007;85(5):569-570
Uveitis masquerade syndromes: diffuse retinoblastoma in an older child.
All-Ericsson C; Economou MA; Landau I; Träisk F; Seregard S
Article: BLOOD. 2006;108(9):3021-3026
Molecular and clinical spectrum of type I plasminogen deficiency: A series of 50 patients.
Tefs K; Gueorguieva M; Klammt J; Allen CM; Aktas D; Anlar FY; Aydogdu SD; Brown D; Ciftci E; Contarini P; Dempfle C-E; Dostalek M; Eisert S; Gökbuget A; Günhan O; Hidayat AA; Hügle B; Isikoglu M; Irkec M; Joss SK; Klebe S; Kneppo C; Kurtulus I; Mehta RP; Ornek K; Schneppenheim R; Seregard S; Sweeney E; Turtschi S; Veres G; Zeitler P; Ziegler M; Schuster V
Article: CLINICAL CANCER RESEARCH. 2006;12(4):1383-1391
The insulin-like growth factor-1 receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells
Girnita A; All-Ericsson C; Economou MA; Åström K; Axelson M; Seregard S; Larsson O; Girnita L
Article: DIAGNOSTIC CYTOPATHOLOGY. 2006;34(1):1-5
Fine-needle aspiration cytology and immunocytochemistry of orbital masses.
Tani E; Seregard S; Rupp G; Söderlund V; Skoog L
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2006;47(1):72-77
Uveal melanoma: A study on incidence of additional cancers in the Swedish population
Bergman L; Nilsson B; Ragnarsson-Olding B; Seregard S
Article: AMERICAN JOURNAL OF OPHTHALMOLOGY. 2005;140(6):1002-1006
Choroidal biopsies for Intraocular tumors of indeterminate origin
Kvanta A; Seregard S; Kopp ED; All-Ericsson C; Landau I; Berglin L
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2005;46(12):4372-4375
Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: Intercorrelation and prognostic implications
Economou MA; All-Ericsson C; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S
Article: JOURNAL OF HOSPITAL INFECTION. 2005;61(3):251-256
Risk factors for endophthalmitis following cataract surgery: a retrospective case-control study.
Wejde G; Samolov B; Seregard S; Koranyi G; Montan PG
Article: ACTA OPHTHALMOLOGICA. 2005;83(3):298-301
The cut-and-paste method for primary pterygium surgery: long-term follow-up
Koranyi G; Seregard S; Kopp ED
Article: GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY. 2005;243(5):427-432
Detection of diabetic retinopathy: a comparison between red-free digital images and colour transparencies.
von Wendt G; Summanen P; Hallnäs K; Algvere P; Heikkilä K; Seregard S
Article: OPHTHALMOLOGY. 2005;112(5):834-840
Ruthenium brachytherapy for uveal melanoma, 1979-2003 - Survival and functional outcomes in the Swedish population
Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
Article: CURRENT EYE RESEARCH. 2005;30(4):259-267
Retinal vascular development and pathologic retinal angiogenesis are not impaired in matrix metalloproteinase-2 deficient mice
Sarman S; van der Ploeg I; Seregard S; Kvanta A
Article: EXPERIMENTAL EYE RESEARCH. 2005;80(2):159-166
Delayed inflammation-associated corneal neovascularization in MMP-2-deficient mice
Samolov B; Steen B; Seregard S; van der Ploeg I; Montan P; Kvanta A
Article: BRITISH JOURNAL OF OPHTHALMOLOGY. 2004;88(11):1422-1424
Epiphora as a side effect of topical mitomycin C
Kopp ED; Seregard S
Article: THROMBOSIS AND HAEMOSTASIS. 2004;92(2):352-357
Characterization of plasminogen variants in healthy subjects and plasminogen mutants in patients with inherited plasminogen deficiency by isoelectric focusing gel electrophoresis
Tefs K; Georgieva M; Seregard S; Tait CR; Luchtman-Jones L; Ziegler M; Hügle B; Schuster V
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2004;45(7):2075-2082
c-Kit-dependent growth of uveal melanoma cells:: A potential therapeutic target?
All-Ericsson C; Girnita L; Müller-Brunotte A; Brodin B; Seregard S; Östman A; Larsson O
Article: BRITISH JOURNAL OF OPHTHALMOLOGY. 2004;88(7):962-967
The Zimmerman-McLean-Foster hypothesis: 25 years later
Singh AD; Rennie IG; Kivela T; Seregard S; Grossniklaus H
Article: BRITISH JOURNAL OF OPHTHALMOLOGY. 2004;88(7):911-914
Cut and paste: a no suture, small incision approach to pterygium surgery
Koranyi G; Seregard S; Kopp ED
Article: OPHTHALMOLOGY. 2004;111(6):1228-1232
Incidence of retinoblastoma from 1958 to 1998 in northern Europe -: Advantages of birth cohort analysis
Seregard S; Lundell G; Svedberg H; Kivelä T
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2004;45(6):1969-1974
Subthreshold transpupillary thermotherapy reduces experimental choroidal neovascularization in the mouse without collateral damage to the neural retina
Ming Y; Algvere PV; Odergren A; Berglin L; van der Ploeg I; Seregard S; Kvanta A
Article: EYE. 2004;18(3):283-289
The EORTC Ophthalmic Oncology Quality of Life Questionnaire module (EORTC QLQ-OPT30).: Development and pre-testing (Phase I-III)
Brandberg Y; Damato B; Kivelä T; Kock E; Seregard S
Article: AMERICAN JOURNAL OF OPHTHALMOLOGY. 2003;136(5):954-955
TIMP-3 mRNA is not overexpressed in Sorsby fundus dystrophy.
Chong NHV; Kvanta A; Seregard S; Bird AC; Luthert PJ; Steen B
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2003;44(8):3282-3287
Uveal melanoma survival in Sweden from 1960 to 1998
Bergman L; Seregard S; Nilsson B; Lundell G; Ringborg U; Ragnarsson-Olding B
Article: ACTA OPHTHALMOLOGICA. 2003;81(2):110-117
Transpupillary thermotherapy of predominantly occult choroidal neovascularization in age-related macular degeneration with 12 months follow-up
Algvere PV; Libert C; Lindgärde G; Seregard S
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2003;44(1):403-408
Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice
Berglin L; Sarman S; van der Ploeg I; Steen B; Ming Y; Itohara S; Seregard S; Kvanta A
Article: ACTA OPHTHALMOLOGICA. 2002;80(6):660-664
Management of alveolar rhabdomyosarcoma of the orbit.
Seregard S
Article: ACTA OPHTHALMOLOGICA. 2002;80(5):531-536
Photodynamic therapy for circumscribed choroidal haemangioma
Landau IME; Steen B; Seregard S
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2002;43(8):2579-2583
Incidence of uveal melanoma in Sweden from 1960 to 1998
Bergman L; Seregard S; Nilsson B; Ringborg U; Lundell G; Ragnarsson-Olding B
Article: ACTA OPHTHALMOLOGICA. 2002;80(3):294-299
A prospective study of children treated for retinoblastoma: Cognitive and visual outcomes in relation to treatment
Ek U; Seregard S; Jacobson L; Oskar K; Trampe EA; Kock E
Article: ACTA OPHTHALMOLOGICA. 2002;80(2):136-143
Age-related maculopathy: pathogenetic features and new treatment modalities
Algvere PV; Seregard S
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2002;43(3):595-602
Structure and function of the N-cadherin/catenin complex in retinoblastoma.
Van Aken EH; Papeleu P; De Potter P; Bruyneel E; Philippé J; Seregard S; Kvanta A; De Laey J-J; Mareel MM
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2002;43(1):1-8
Insulin-like growth factor-1 receptor in uveal melanoma: A predictor for metastatic disease and a potential therapeutic target
All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
Article: BRITISH JOURNAL OF OPHTHALMOLOGY. 2001;85(10):1208-1212
Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
Article: INTERVENTIONAL NEURORADIOLOGY. 2001;7(3):193-199
Direct puncture and sclerotherapy with Sotradecol^® -: Orbital lymphatic malformations
Svendsen PA; Wikholm G; Rodriguez M; Enoksson P; Frisén L; Strömland K; Seregard S
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2001;42(10):2153-2156
Association of HLA class I and class II antigen expression and mortality in uveal melanoma
Ericsson C; Seregard S; Bartolazzi A; Levitskaya E; Ferrone S; Kiessling R; Larsson O
Article: SEMINARS IN OPHTHALMOLOGY. 2001;16(2):90-96
Transpupillary thermotherapy of occult CNV with no or minimally classic CNV in age-related macular degeneration.
Algvere PV; Libert C; Seregard S
Article: THROMBOSIS AND HAEMOSTASIS. 2001;85(6):1004-1010
Homozygous and compound-heterozygous type I plasminogen deficiency is a common cause of ligneous conjunctivitis.
Schuster V; Zeitler P; Seregard S; Ozcelik U; Anadol D; Luchtman-Jones L; Meire F; Mingers AM; Schambeck C; Kreth HW
Article: ACTA OPHTHALMOLOGICA. 2001;79(1):91-93
Angiolymphoid hyperplasia with eosinophilia should not be confused with Kimura's disease
Seregard S
Article: ACTA OPHTHALMOLOGICA. 2001;79(1):19-22
Transpupillary thermotherapy as an adjunct to ruthenium plaque radiotherapy for choroidal melanoma
Seregard S; Landau I
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 2001;42(2):313-317
Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma
Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
Article: EYE. 2000;14(Pt 6):839-846
Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study
Brandberg Y; Kock E; Oskar K; Af Trampe E; Seregard S
Article: CURRENT EYE RESEARCH. 2000;21(3):684-690
Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization
Kvanta A; Shen WY; Sarman S; Seregard S; Steen B; Rakoczy E
Article: GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY. 2000;238(8):682-689
Cellular migration into neural retina following implantation of melanin granules in the subretinal space
Crafoord S; Kopp ED; Seregard S; Algvere PV
Article: ANTICANCER RESEARCH. 2000;20(3B):1969-1975
Improvement of the recurrence-free interval using biological adjuvant therapy in uveal melanoma.
Tallberg T; Uusitalo R; Sarna S; Seregard S; Werschnik C
Article: EXPERIMENTAL EYE RESEARCH. 2000;70(4):419-428
Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization
Kvanta A; Sarman S; Fagerholm P; Seregard S; Steen B
Article: ACTA OPHTHALMOLOGICA. 2000;78(1):104-106
Pigmented spindle cell naevus of Reed presenting in the conjunctiva
Seregard S
Article: EXPERIMENTAL EYE RESEARCH. 1999;69(6):671-676
Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
Seregard S; Oskarsson M; Spângberg B
Article: EYE. 1999;13:577-583
Blue light induced apoptosis in rat retina
Wu JM; Seregard S; Spangberg B; Oskarsson M; Chen EP
Article: ACTA OPHTHALMOLOGICA. 1999;77(4):414-417
Long-term survival after ruthenium plaque radiotherapy for uveal melanoma. A meta-analysis of studies including 1,066 patients
Seregard S
Article: AIDS. 1999;13(9):1071-1075
BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS
Bratt G; Hammarin AL; Grandien M; Hedquist BG; Nennesmo I; Sundelin B; Seregard S
Article: ACTA OPHTHALMOLOGICA. 1999;77(1):91-98
Panorama of orbital space-occupying lesions. The 24-year experience of a referral centre
Seregard S; Sahlin S
Article: OPHTHALMOLOGY. 1999;106(1):129-132
Identification of BK virus in a patient with Acquired Immune Deficiency Syndrome and bilateral atypical retinitis
Hedquist BG; Bratt G; Hammarin AL; Grandien M; Nennesmo I; Sundelin B; Seregard S
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 1998;39(11):2194-2200
Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes
Steen B; Sejersen S; Berglin L; Seregard S; Kvanta A
Article: OPHTHALMOLOGY. 1998;105(3):485-491
Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma
Seregard S; Spångberg B; Juul C; Oskarsson M
Article: EXPERIMENTAL EYE RESEARCH. 1997;65(5):595-602
Localization of adenosine receptor messenger RNAs in the rat eye
Kvanta A; Seregard S; Sejersen S; Kull B; Fredholm BB
Article: GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY. 1997;235(5):306-312
Photoreceptor decay over time and apoptosis in experimental retinal detachment
Berglin L; Algvere PV; Seregard S
Article: ACTA OPHTHALMOLOGICA. 1997;75(2):148-154
Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma
Seregard S; Lundell G; Lax I; Trampe EA; Kock E
Article: ACTA OPHTHALMOLOGICA. 1997;75(1):11-16
Results following episcleral ruthenium plaque radiotherapy for posterior uveal melanoma - The Swedish experience
Seregard S; afTrampe E; Lax I; Kock E; Lundell G
Article: EXPERIMENTAL EYE RESEARCH. 1996;63(5):511-518
Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma
Kvanta A; Steen B; Seregard S
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 1996;37(9):1929-1934
Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor
Kvanta A; Algvere PV; Berglin L; Seregard S
Article: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. 1996;37(7):1451-1458
PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma
Seregard S; Oskarsson M; Spangberg B
Article: LAKARTIDNINGEN. 1996;93(21):2067-2069
[Ophthalmology on CD-ROM. See more and better with new technology].
Seregard S
Article: JOURNAL OF CLINICAL PATHOLOGY. 1996;49(4):338-342
Cell growth and p53 expression in primary acquired melanosis and conjunctival melanoma
Seregard S
Article: LAKARTIDNINGEN. 1996;93(12):1133-1135
[A study of children with retinoblastoma. Diagnosis is often delayed].
Seregard S; Ek U; Preisler G; af Trampe E; Jacobson L; Oskar K; Illerståhl I; Kock E
Article: ACTA OPHTHALMOLOGICA. 1995;73(6):491-495
Proliferating cell nuclear antigen colocalization with corneal epithelial stem cells and involvement in physiological cell turnover
Gan LS; vanSetten G; Seregard S; Fagerholm P
Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 1995;19(11):1286-1293
GIANT-CELL ANGIOFIBROMA - A DISTINCTIVE ORBITAL TUMOR IN ADULTS
TOS APD; SEREGARD S; CALONJE E; CHAN JKC; FLETCHER CDM
Article: OPHTHALMOLOGY. 1995;102(10):1524-1529
PREVALENCE OF PRIMARY ACQUIRED MELANOSIS AND NEVI OF THE CONJUNCTIVA AND UVEA IN THE DYSPLASTIC NEVUS SYNDROME - A CASE-CONTROL STUDY
SEREGARD S; AFTRAMPE E; MANSSONBRAHME E; KOCK E; BERGENMAR M; RINGBORG U
Article: ACTA OPHTHALMOLOGICA. 1995;73(4):340-344
Prognostic indicators following enucleation for posterior uveal melanoma. A multivariate analysis of long-term survival with minimized loss to follow-up.
Seregard S; Kock E
Article: LAKARTIDNINGEN. 1995;92(4):277-280
[Orbital panorama. A 20-year perspective].
Seregard S; Kock E; Tengroth B
Visa fler

Alla övriga publikationer

Corrigendum: ONCOGENE. 2023;42(11):858
IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma (vol 41, pg 600, 2022)
Song D; Cismas S; Crudden C; Trocme E; Worrall C; Suleymanova N; Lin T; Zheng H; Seregard S; Girnita A; Girnita L
Editorial comment: OPHTHALMOLOGY. 2021;128(9):1369-1371
Incidence of Retinoblastoma Has Increased: Results from 40 European Countries.
Stacey AW; Bowman R; Foster A; Kivelä TT; Munier FL; Cassoux N; Fabian ID; Global Retinoblastoma Study Group
Editorial comment: OPHTHALMOLOGY. 2021;128(7):1107-1109
Presenting Symptoms Are Associated with Uveal Melanoma-Related Death
Fili M; Seregard S; Stalhammar G
Editorial comment: CLINICAL NUCLEAR MEDICINE. 2020;45(5):370-371
Eye Symptoms in a Patient With Prostate Cancer
Kairemo K; Kangasmaeki A; Joensuu T; Seregard S
Letter: ACTA OPHTHALMOLOGICA. 2018;96(8):e1040-e1041
Intra-arterial chemotherapy for retinoblastoma in Sweden - evaluation of treatment efficacy and complications
Radros J; All-Eriksson C; Pal N; Holm S; Seregard S; Soderman M; Arnberg F; Holmin S
Review: ACTA OPHTHALMOLOGICA. 2016;94(5):427-433
Drusen maculopathy: a risk factor for visual deterioration
Algvere PV; Kvanta A; Seregard S
Editorial comment: EUROPEAN JOURNAL OF OPHTHALMOLOGY. 2015;25(2):80
EJO talks to Stefan Seregard, President of the European Society of Ophthalmology, about the SOE 2015 Congress and what makes the SOE Congress so unique
Seregard S
Review: CELLULAR AND MOLECULAR LIFE SCIENCES. 2014;71(13):2403-2427
Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation
Girnita L; Worrall C; Takahashi S-I; Seregard S; Girnita A
Editorial comment: ACTA OPHTHALMOLOGICA. 2014;92(4):303-304
The Nordic Ophthalmological Congress revisits Stockholm.
Seregard S
Review: DEVELOPMENTS IN OPHTHALMOLOGY. 2013;52:114-123
Radiation therapy: posterior segment complications.
Seregard S; Pelayes DE; Singh AD
Review: DEVELOPMENTS IN OPHTHALMOLOGY. 2013;52:36-57
Radiation therapy: uveal tumors.
Seregard S; Pelayes DE; Singh AD
Editorial comment: BRITISH JOURNAL OF OPHTHALMOLOGY. 2012;96(4):473-474
Retinoblastoma: direct chemotherapeutic drug delivery into the vitreous cavity
Seregard S; Singh AD
Letter: ARCHIVES OF OPHTHALMOLOGY. 2012;130(9):1230-1231
Angle Involvement and Glaucoma in Patients With Biopsy-Proven Iris Melanoma: A Response Reply
Khan S; Finger PT; Yu G-P; Razzaq L; Jager MJ; de Keizer RJW; Sandkull P; Seregard S; Gologorsky D; Schefler AC; Murray TG; Kivela T; Giuliari GP; McGowan H; Simpson ER; Corriveau C; Coupland SE; Damato BE
Editorial comment: ACTA OPHTHALMOLOGICA. 2011;89(8):699-700
Gullstrand's Nobel Prize. 100 years and counting.
Seregard S
Review: BRITISH JOURNAL OF OPHTHALMOLOGY. 2010;94(5):532-535
Topical chemotherapy for ocular surface squamous neoplasia: current status
Sepulveda R; Pe'er J; Midena E; Seregard S; Dua HS; Singh AD
Letter: EYE. 2010;24(2):386
Fine-needle aspiration biopsy in lacrimal gland pleomorphic adenoma
Kopp ED; Sahlin S; Tani E; Skoog L; Seregard S
Letter: ACTA OPHTHALMOLOGICA. 2009;87(8):914-916
Malignant melanoma of soft parts arising from Tenon's capsule
Sandkull P; Seregard S
Letter: ACTA OPHTHALMOLOGICA. 2009;87(8):916-917
Carcinoid presenting as extrinsic eye muscle metastasis
Bohman E; Sahlin S; Seregard S
Editorial comment: ACTA OPHTHALMOLOGICA. 2009;87(6):586-587
To biopsy or not to biopsy?
Seregard S
Editorial comment: ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. 2009;133(8):1197-1198
The 7th Edition AJCC Staging System for Eye Cancer An International Language for Ophthalmic Oncology
Finger PT
Editorial comment: ACTA OPHTHALMOLOGICA. 2009;87(2):148
Who's the faster runner: the cheetah or the rabbit?
Seregard S
Editorial comment: ACTA OPHTHALMOLOGICA. 2008;86(8):818-820
Swedish ophthalmology faces up to the 21st century.
Seregard S
Editorial comment: BRITISH JOURNAL OF OPHTHALMOLOGY. 2008;92(6):727-728
Primary transpupillary thermotherapy of "small" choroidal melanoma: is it safe?
Singh AD; Kivelä T; Seregard S; Robertson D; Bena JF
Editorial comment: ACTA OPHTHALMOLOGICA. 2008;86(4):352-355
Shall we use Avastin or Lucentis for ocular neovascularization?
Algvere PV; Kvanta A; Seregard S
Editorial comment: ACTA OPHTHALMOLOGICA. 2008;86(2):235-236
Interview with Stefan Seregard
Magnusson G
Letter: ACTA OPHTHALMOLOGICA. 2007;85(5):576-577
Oncocytoma of the lacrimal gland
Economou MA; Seregard S; Sahlin S
Letter: ACTA OPHTHALMOLOGICA. 2007;85(3):341-343
Mantle cell lymphoma of the iris
Economou MA; Dafgard Kopp E; All-Ericsson C; Seregard S
Review: SURVEY OF OPHTHALMOLOGY. 2006;51(5):461-481
Photochemical damage of the retina
Wu J; Seregard S; Algvere PV
Review: ACTA OPHTHALMOLOGICA. 2006;84(1):4-15
Age-related maculopathy and the impact of blue light hazard
Algvere PV; Marshall J; Seregard S
Review: ACTA OPHTHALMOLOGICA. 2005;83(3):278-288
Nordic research in ophthalmology
Heijl A; Algvere PV; Alm A; Andersen N; Bauer B; Carlsson JO; Ehinger B; Eide N; Fledelius H; Foerster M; Hjortdal J; Holmström G; Hovding G; Kivelä T; la Cour M; Lindblom B; Moller-Pedersen T; Nikoskelainen E; Prause JU; Riise R; Rosenberg T; Seregard S; Stefánsson E; Tarkkanen A; Tervo T; Tornqvist K; Zetterström C
Review: OPHTHALMOLOGY CLINICS OF NORTH AMERICA. 2005;18(1):75-84
Uveal melanoma: epidemiologic aspects.
Singh AD; Bergman L; Seregard S
Letter: BRITISH JOURNAL OF OPHTHALMOLOGY. 2005;89(3):392
Comments on using fibrin glue in pterygium surgery - Response
Koranyi G; Seregard S; Kopp ED
Review: SURVEY OF OPHTHALMOLOGY. 2004;49(4):419-428
Sunlight exposure and pathogenesis of uveal melanoma
Singh AD; Rennie IG; Seregard S; Giblin M; McKenzie J
Corrigendum: EUROPEAN JOURNAL OF OPHTHALMOLOGY. 2004;14(4):360
Detection of diabetic retinopathy -: a comparison between red-free digital images and colour transparencies (vol 14, pg 169, 2004)
von Wendt G; Summanen P; Hallnäs K; Algvere P; Heikkilä K; Seregard S
Editorial comment: ACTA OPHTHALMOLOGICA. 2003;81(5):427-429
Drusen maculopathy: a risk factor for AMD. Can we prevent visual loss?
Algvere PV; Seregard S
Review: SURVEY OF OPHTHALMOLOGY. 2003;48(4):369-388
Ligneous conjunctivitis
Schuster V; Seregard S
Published conference paper: ACTA OPHTHALMOLOGICA. 2002;80(4):387-394
Photoreceptor survival in transplantation of autologous iris pigment epithelial cells to the subretinal space
Crafoord S; Geng LJ; Seregard S; Algvere PV
Published conference paper: ACTA OPHTHALMOLOGICA. 2001;79(6):580-584
The Swedish national survey of surgical excision for submacular choroidal neovascularization (CNV)
Berglin L; Algvere P; Olivestedt G; Crafoord S; Stenkula S; Hansson LJ; Tomic Z; Kvanta A; Seregard S
Published conference paper: ACTA OPHTHALMOLOGICA. 2001;79(5):509-514
Experimental transplantation of autologous iris pigment epithelial cells to the subretinal space
Crafoord S; Geng LJ; Seregard S; Algvere PV
Published conference paper: ACTA OPHTHALMOLOGICA. 2000;78(2):122-129
Cyclosporine treatment of RPE allografts in the rabbit subretinal space
Crafoord S; Algvere PV; Kopp ED; Seregard S
Letter: OPHTHALMOLOGY. 1999;106(12):2232
BK virus retinitis - Reply
Seregard S
Editorial comment: ACTA OPHTHALMOLOGICA. 1999;77(5):604-607
A peripapillary pigmented lesion.
Seregard S
Published conference paper: ACTA OPHTHALMOLOGICA. 1999;77(3):247-254
Long-term outcome of RPE allografts to the subretinal space of rabbits.
Crafoord S; Algvere PV; Seregard S; Kopp ED
Published conference paper: ACTA OPHTHALMOLOGICA. 1999;77(3):343-346
Phakomatous choristoma may be located in the eyelid or orbit or both
Seregard S
Published conference paper: BLOOD. 1999;93(10):3457-3466
Compound-heterozygous mutations in the plasminogen gene predispose to the development of ligneous conjunctivitis.
Schuster V; Seidenspinner S; Zeitler P; Escher C; Pleyer U; Bernauer W; Stiehm ER; Isenberg S; Seregard S; Olsson T; Mingers AM; Schambeck C; Kreth HW
Published conference paper: JOURNAL OF CATARACT AND REFRACTIVE SURGERY. 1998;24(6):793-800
Risk of acute suprachoroidal hemorrhage with phacoemulsification.
Eriksson A; Koranyi G; Seregard S; Philipson B
Review: SURVEY OF OPHTHALMOLOGY. 1998;42(4):321-350
Conjunctival melanoma
Seregard S
Review: ACTA OPHTHALMOLOGICA. 1996;74(4):315-329
Posterior uveal melanoma. The Swedish perspective.
Seregard S
Other: ACTA OPHTHALMOLOGICA. 1995;73(5):464-466
Squamous spindle cell carcinoma of the conjunctiva. Fatal outcome of a plerygium-like lesion.
Seregard S; Kock E
Other: ACTA OPHTHALMOLOGICA. 1995;73(5):457-459
Orbital presentation of ethmoid sinus adenocarcinoma.
Seregard S; Kock E
Letter: BRITISH JOURNAL OF OPHTHALMOLOGY. 1995;79(2):194-195
Intravitreal chemotherapy for recurrent retinoblastoma in an only eye.
Seregard S; Kock E; af Trampe E
Other: ACTA OPHTHALMOLOGICA. 1995;73(2):184
MALIGNANT-MELANOMA OF THE CONJUNCTIVA AND POTENTIAL PRECURSOR LESIONS
SEREGARD S
Visa fler

Anställningar

Professor Emeritus/Emerita, Klinisk neurovetenskap, Karolinska Institutet, 2024-2027

Examina och utbildning

Docent, Oftalmiatrik, Karolinska Institutet, 1997

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI